Skip to main content
Signal8

Nicacio Leonardo Viana

SEC insider (Form 3/4/5 filer). CIK 0002064901. Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 16, 2026. Located in NORWOOD, MA.

Companies Nicacio Leonardo Viana has filed insider reports for

  • Corbus Pharmaceuticals Holdings, Inc. (CRBP): Officer, Chief Medical Officer
  • Protara Therapeutics, Inc. (TARA): Officer, Chief Medical Officer
Nicacio Leonardo Viana profile photo

Nicacio Leonardo Viana

CIK: 0002064901

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Corbus Pharmaceuticals Holdings, Inc. logo
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Officer
Protara Therapeutics, Inc. logo
TARA

Protara Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Aug 16, 2026
    Award
    Direct
    58.3K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 16, 2026
    Award
    Direct
    26K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Apr 15, 2025
    Award
    Direct
    50K shares-

1-3 of 3